Gastrointestinal kanamayla taburcu olan hastalarda anemi prevalansı ve klinik yaklaşım

Abstract

Listen

Translate article

Background and Aims: Acute gastrointestinal system hemorrhages are frequent, and anemia is frequently seen in patients with acute gastrointestinal system bleeding after hospital discharge. Studies intended for patient follow-ups after discharge and anemia treatment are limited, and this topic has no guidelines. This study aimed to evaluate anemia prevalence and clinical approach in patients with acute gastrointestinal system bleeding after hospital discharge and during 3 months of follow-up. Materials and Method: This study retrospectively evaluated 197 patients with acute gastrointestinal system bleeding who were treated at our hospital between January 2017 and May 2018. Upon discharge, anemia was accepted as hemoglobin levels of < 13 g/dL in men and 12 g/dL in women according to the World Health Organization criteria. Results: Of these patients, 129 underwent upper gastrointestinal endoscopy; 3 enteroscopy; 45 lower gastrointestinal endoscopy; 8 upper and lower gastrointestinal endoscopy; 2 upper, middle, and lower gastrointestinal endoscopies; and 10 did not undergo endoscopy. Additionally, 69 patients underwent therapeutic endoscopic treatments. The mean hospitalization duration was 10 ± 13.84 days, and 67% of patients had erythrocyte transfusion with a mean value of 3.5 ± 5.89 units during hospitalization. The mean hemoglobin rate was 9.85 ± 1.67 g/dL upon hospital discharge. Of the patients, 92.4% (female: 91.1%, male: 93.2%; upper gastrointestinal bleeding: 93.9%, middle gastrointestinal bleeding: 100%, lower gastrointestinal bleeding: 86.8%) had anemia upon hospital discharge and 9.7% underwent iron deficiency treatment. Of all 197 patients, 33% were evaluated 3 months after discharge from the hospital and 80% of these patients have ongoing anemia. Conclusions: Anemia frequency is high when patients with acute gastrointestinal system bleeding are discharged. Most patients are discharged without receiving a prescription for anemia. In the follow-up, control applications are inadequate and anemia persists in patients. A wider range of patient studies on the treatment application and adherence, as well as guidelines from the consensus body on this issue, is necessary.